# EDGAR Filing Document

**Accession Number:** 0002048309
**File Stem:** 0002048309-26-000005
**Filing Date:** 2026-6
**Character Count:** 9132
**Document Hash:** 0b19094438ce15d32800167bfdf46391
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002048309-26-000005.hdr.sgml**: 20260610

**ACCESSION NUMBER**: 0002048309-26-000005

**CONFORMED SUBMISSION TYPE**: 4/A

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260417

**FILED AS OF DATE**: 20260610

**DATE AS OF CHANGE**: 20260610

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Munagala Dinakar
- **CENTRAL INDEX KEY:** 0002048309

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41139
- **FILM NUMBER:** 261080624

**MAIL ADDRESS:**
- **STREET 1:** C/O BLAIZE, INC.
- **STREET 2:** 4659 GOLDEN FOOTHILL PARKWAY, SUITE 206
- **CITY:** EL DORADO HILLS
- **STATE:** CA
- **ZIP:** 95762
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Blaize Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001871638
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 4659 GOLDEN FOOTHILL PARKWAY, SUITE 206
- **CITY:** EL DORADO HILLS
- **STATE:** CA
- **ZIP:** 95762
- **BUSINESS PHONE:** (916) 347-0050

**MAIL ADDRESS:**
- **STREET 1:** 4659 GOLDEN FOOTHILL PARKWAY, SUITE 206
- **CITY:** EL DORADO HILLS
- **STATE:** CA
- **ZIP:** 95762

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BurTech Acquisition Corp.
- **DATE OF NAME CHANGE:** 20210708

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4/A

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Munagala Dinakar<br><sub>(Last) (First) (Middle)</sub><br>C/O BLAIZE HOLDINGS, INC.<br>4659 GOLDEN FOOTHILL PARKWAY, SUITE 206<br><sub>(Street)</sub><br>EL DORADO HILLS, CA 95762<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-04-17 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Executive Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Blaize Holdings, Inc. [ BZAI ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-04-17 |  | S |  | 50000<sup>(1)(2)</sup> | D | 2.54<sup>(3)</sup> | 501422<sup>(4)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (right to purchase) | $0.57 |  |  |  |  |  |  | <sup>(5)</sup> | 2033-09-18 | Common Stock | 4150347 |  | 4150347<sup>(1)</sup> | D |  |
| Restricted Stock Units | <sup>(6)</sup> |  |  |  |  |  |  | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 2421971 |  | 2421971 | D |  |
| Earnout Shares | <sup>(8)</sup> |  |  |  |  |  |  | <sup>(8)</sup> | 2030-01-13 | Common Stock | 1371303 |  | 1371303 | D |  |
| Employee Stock Option (right to purchase) | $1.18 |  |  |  |  |  |  | <sup>(9)</sup> | 2034-10-23 | Common Stock | 5755192 |  | 5755192 | D |  |
| Employee Stock Option (right to purchase) | $1.29 |  |  |  |  |  |  | <sup>(10)</sup> | 2027-03-15 | Common Stock | 114650 |  | 114650 | D |  |
| Employee Stock Option (right to purchase) | $14.62 |  |  |  |  |  |  | <sup>(10)</sup> | 2028-11-12 | Common Stock | 176503 |  | 176503 | D |  |

---

### Footnotes:

(1) On April 20, 2026, the reporting person filed a Form 4 (the "Original Form 4") which inadvertently reported that the reporting person exercised a stock option and sold the underlying stock. Instead, as reported in this amendment (this "Amendment"), the reporting person did not exercise the stock option and in fact sold the same number of shares of stock as originally reported in the Original Form 4 but from his Table I holdings. The reporting person's other holdings have been restated for convenience, and there have been no transactions in such holdings since the Original Form 4. The order of the footnotes in this Explanation of Responses section have been conformed to the above changes.

(2) The reported sales were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025.

(3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.63, inclusive. Upon request by the SEC staff, the Issuer,or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

(4) In the reporting person's prior Form 4 filings, earnout shares and unvested restricted stock units had been reported in Table I. These holdings have been moved to Table II, and there have been notransactions in such holdings since the reporting person's last Form 4 filing.

(5) The stock option vests in 36 substantially equal monthly installments beginning on October 19, 2023.

(6) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

(7) The restricted stock units vest 25% on December 1, 2027, and quarterly thereafter commencing on March 1, 2028.

(8) On January 13, 2025, the date of the Issuer's business combination, the reporting person received earnout shares in respect of the Issuer's business combination. Each eanout share represents acontingent right to receive one share of the Issuer's common stock if the trading price of the Issuer's common stock exceeds certain thresholds for 20 of 30 consecutive trading days post-closing of the
Issuer's business combination.

(9) The stock option vests as to one third of the underlying shares on July 1, 2025 and thereafter in 24 equal monthly installments.

(10) The stock option to purchase one share of the Issuer's common stock for each stock option is fully vested and exercisable.

**Signature:** /s/ Harminder Sehmi, as Attorney-in-Fact  
**Date:** 2026-06-10

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**